Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes
- 18 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 28 (13) , 2245-2254
Abstract
Myotonic dystrophy type 1 (DM1) is an autosomal dominant inherited disorder caused by expansion of a germline and somatically unstable CTG repeat in the DMPK gene. Previously, CTG repeat length at birth has been correlated to patient age at symptom onset. Attempts to correlate CTG repeat length with progressive DM1 phenotypes, such as muscle power, have proven difficult. To better correlate genotype with progressive phenotypes, we have measured CTG repeat tract length and screened for interrupting variant repeats in 192 study participants from a well-characterized Canadian cohort. We have assessed genotype-phenotype correlations with nine progressive measures of skeletal muscle power and respiratory function. We have built statistical models that include confounding factors such as sex, age, height and weight to further explain variation in muscle power. Our analysis reveals a strong correlation between DM1 genotype and respiratory function and skeletal muscle power, as part of a complex model that includes additional modulators such as sex, age, height, weight and the presence or absence of interrupting variant repeats. Distal skeletal muscle measurements, such as hand pinch and grip strength, show the strongest correlation with disease genotype. Detailed analysis of CTG repeat length, and incorporation of confounding factors, greatly improves the predictive ability of these models. They reveal a greater genetic influence on individual progressive phenotypes than on age at symptom onset and for clinical trials will help optimize stratification and explain patient variability. They will also help practitioners prioritize assessment of the muscular power measurements that correlate best with disease severity.Keywords
Funding Information
- Centre de recherche médicale de l’Université de Sherbrooke
- Corporation de recherche et d’action sur les maladies héréditaires
- Fondation du Grand défi Pierre Lavoie
- Fonds de la Recherche du Québec en Santé
- Fondation du Grand défi Pierre Lavoie
- Canadian Institutes of Health Research (JNM-108412)
- Marigold Foundation
- Muscular Dystrophy UK (RA3/3033)
This publication has 40 references indexed in Scilit:
- Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)Muscle & Nerve, 2007
- Small increase in triplet repeat length of cerebellum from patients with myotonic dystrophyHuman Genetics, 1996
- Complex gene conversion events in germline mutation at human minisatellitesNature Genetics, 1994
- Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytesAnnals of Neurology, 1994
- Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophyHuman Molecular Genetics, 1993
- An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular DystrophyScience, 1992
- Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the GeneScience, 1992
- Cloning of the essential myotonic dystrophy region and mapping of the putative defectNature, 1992
- Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophyNature, 1992
- Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family memberCell, 1992